Northwire Canada EditionSunday, October 18, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0% GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0%
Financings

Ventripoint arranges $542,591 debt settlement

By The Northwire Desk — AI Analysis Nov 06, 2025 · 18:04 VPT · 0.10 Ventripoint Diagnostics Ltd
VPT · Price

Executive Summary

  • Ventripoint Diagnostics Ltd. has entered into agreements to settle an aggregate debt of $542,591.50 owed to arm's-length creditors.
  • The settlement is being executed through the issuance of 5,425,915 common shares at a price of $0.10 per share.
  • The company intends to use this transaction to preserve cash for business development, pending approval from the TSX Venture Exchange.

Key Details

  • Debt Settled: Aggregate amount of $542,591.50 owed to certain arm's-length creditors.
  • Consideration: Issuance of 5,425,915 common shares.
  • Price Per Share: $0.10 CAD.
  • Hold Period: The issued shares are subject to a hold period of four months and one day.
  • Strategic Rationale: The corporation determined to satisfy the indebtedness with shares to preserve cash for the development of its business.
  • Regulatory Status: The issuance of shares is subject to approval by the TSX Venture Exchange.
Read the original news release →

More from Ventripoint Diagnostics Ltd

Jun 26, 2026 · 08:10

AI cardiac imaging startup scaling niche partnerships while navigating a critical $55k cash balance and negative working capital.

M&A / Property Jun 16, 2026 · 09:11

AI cardiac imaging startup scales commercial partnerships but remains cash-constrained and pre-revenue at scale.

Other Apr 28, 2026 · 08:00

Ventripoint Advances China Entry Amidst Persistent Dilution Concerns

Regulatory Apr 20, 2026 · 08:50

Ventripoint Wins Gold Edison Award But Cash Burn and Dilution Risks Persist

Other Apr 16, 2026 · 11:00

TSXV Venture Exchange Listed Cardiac Imaging Platform

M&A / Property Apr 01, 2026 · 22:50

Ventripoint Diagnostics Announces Collaboration with the Health Division of the Montecristo Group

M&A / Property